The pro- and anti-tumor role of ILC2s

被引：22

作者：

Trabanelli, Sara ^{[1
]}

Chevalier, Mathieu F. ^{[2
,3
,4
]}

Derre, Laurent ^{[2
]}

Jandus, Camilla ^{[1
]}

机构：

[1] Univ Lausanne, UNIL CHUV, Dept Oncol, CH-1066 Epalinges, Switzerland

[2] Univ Hosp Lausanne CHUV, Urol Res Unit, CH-1011 Lausanne, Switzerland

[3] Hop St Louis, Lab Human Immunol Pathophysiol & Immunotherapy, INSERM U976, Paris, France

[4] Univ Paris, Hop St Louis, Inst Rech St Louis, Paris, France

来源：

SEMINARS IN IMMUNOLOGY | 2019年 / 41卷

基金：

瑞士国家科学基金会;

关键词：

Group-2 innate lymphoid cells; ILC2; Cancer; Tumor immunoregulation; INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR BCL11B; T-CELLS; TYPE-2; IMMUNITY; FACTOR GATA3; INFLAMMATION; EXPRESSION; GROWTH; IL-33; CARCINOGENESIS;

D O I：

10.1016/j.smim.2019.04.004

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Group 2 innate lymphoid cells (ILC2s) are critical for the initiation of type 2 inflammatory diseases. However, ILC2s are also involved in the establishment of the immune microenvironment during tumor development, growth and metastasization. In this context, ILC2s have been shown to be either tumor-suppressive or tumor-promoting according to the tumor type, the cytokine secreted and the other immune cells that are, in turn, recruited and/or activated.

引用

页数：6

共 50 条

[41] ILC2s in cancer: context matters
Melanie Bruchard
Francois Ghiringhelli
Nature Immunology, 2021, 22 : 804 - 806
[42] ICAM-1 in ILC2s
Dempsey, Laurie A.
NATURE IMMUNOLOGY, 2018, 19 (09) : 901 - 901
[43] Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo
Pauline Andreu
Lisa M. Coussens
Cancer and Metastasis Reviews, 2010, 29 : 309 - 316
[44] Systematic review: the effect of radiotherapy on neutrophils in cancer, pro- vs anti-tumor response
Raymakers, Leon
Demmers, Thijs
Meijer, Gert
Molenaar, Quintus Izaak
Olofsen, Patricia
Intven, Martijn
Leusen, Jeanette
Daamen, Lois
RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5189 - S5191
[45] Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
DeNardo, David G.
Andreu, Pauline
Coussens, Lisa M.
CANCER AND METASTASIS REVIEWS, 2010, 29 (02) : 309 - 316
[46] PRO- VERSUS ANTI-TUMOR ACTIVITIES OF MICROGLIA/MACROPHAGES: EXPERIMENTAL AND MATHEMATICAL MODELING APPROACHES
Castillo, L. D. R. Cisneros
Toma, A.
Buzug, T. M.
Regnier-Vigouroax, A.
GLIA, 2013, 61 : S214 - S214
[47] The role of ILC2s in neonatal type 2 immunity bias and allergen sensitization
Steer, Catherine A.
Allinger, Patricia
Takei, Fumio
JOURNAL OF IMMUNOLOGY, 2016, 196
[48] A role for ILC2s, ILC3s and the NLRP3 inflammasome in different forms of asthma
Umetsu, Dale T.
Kim, Hye-Young
Chang, Ya-Jen
CYTOKINE, 2014, 70 (01) : 26 - 26
[49] A role for IL-33-activated ILC2s in eosinophilic vasculitis
Kotas, Maya E.
Dion, Jeremie
Van Dyken, Steven
Ricardo-Gonzalez, Roberto R.
Danel, Claire J.
Taille, Camille
Mouthon, Luc
Locksley, Richard M.
Terrier, Benjamin
JCI INSIGHT, 2021, 6 (12)
[50] ILC2s masquerade as ILC1s to drive chronic disease
Gabrielle T Belz
Nature Immunology, 2016, 17 : 611 - 612

← 1 2 3 4 5 →